The 15 most kick-ass pharma products of the past 15 years
Magazine article
Out of Africa
Withdrawal of USAID is fanning winds of entrepreneurial change
Big appetite
GLP-1 boom is exposing pharma supply chains
Health space odyssey
Preventative revolution – redefining the role of GLP-1s
Apocalypse now?
Dismantling health stigma in ’26 – examining the role for pharma
In therapies
Ten exciting new pharmaceutical drugs emerging in 2026
Happy talk…
The Briefing Room – what next for healthcare communications?
The long goodbye
Can the problem of late hospital patient discharge be solved?
Heavy headlines
Could GLP-1 obesity drugs break pharma’s safety infrastructure?
One direction
Unlocking next chapter – why the latest investment fund matters
The man machine
AI is creating a new market where the super employee is king
Ahead of the curve
Oncology in the NHS – could this be pharma’s moment?
Through the barricades
Dismantling health stigma – examining the role for pharma
Sharp focus
Digital healthcare – shaping a new type of patient experience
Formation changes
Who, where and when? Redrawing your NHS stakeholder map for 2026
